Small molecules inducing CCAAT/enhancer binding protein alpha: A new strategy for treating AML

Hisashi Takei

Presentation information

Poster Session

Sat. Oct, 13

Poster Session 2-4 AML: Clinical （2）

Sat. Oct 13, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Masaharu Nohgawa (Department of Hematology, Japanese Red Cross Socirty Wakayama Medical center)

[PS2-4-1] Small molecules inducing CCAAT/enhancer binding protein alpha: A new strategy for treating AML

Hisashi Takei^1,2, Sridhar Radhakrishnan³, Ikei Kobayashi², Susumu Kobayashi^2,4,5 (1.Department of Hematology, Gunma University Graduate School of Medicine, Japan, 2.Beth Israel Deaconess Medical Center and Harvard Medical School, USA, 3.Cancer Science Institute of Singapore, SINGAPORE, 4.Harvard Stem Cell Institute, Harvard Medical School, USA, 5.Division of Translational Genomics, National Cancer Center Japan)

Abstract password authentication.
Password is written on a program and abstract book.